English

WRITE YOUR STORY

Share your stories with us and inspire
others like you!

C OM M UNI TY

Abhishek Kumar Singh, the 21year-old millionaire in

pharmaceuticals industry
This is a community article contributed by Young Entrepreneurs
22 December 2016

FACEBOOK

The Beginning

Save web pages as PDF manually or automatically w ith PDFmyURL

In December 2006, Abhishek Singh launched the first 90 generics in the pharma
isolated market of Lebanon. In its first year these cost effective generics
received more than 1 million users who could not afford branded medicines in
their own county. This new avenue of choice was built entirely by Abhishek Singh,
21-year-old with no previous extensive work expertise in pharmaceuticals
industry. According to CNBC, Singh learned everything he needed to know
through practical experience at pharma manufacturing units, and proposed to
develop 4,000 generics in the next decade as a core goal.
The inspiring bit of this young one which shall attract ones attention has been;
was that of Abhishek Singh, the 21-year-old millionaire (fortunately millionaire at
21!), who sold his New Generics to much in need countries such as Lebanon,
Brazil, Senegal for millions!
Its quite an interesting story actually: Abhishek Singh started using the
Save web pages as PDF manually or automatically w ith PDFmyURL

MOST POPULAR
POPU LAR

She got kicked out of

malls and got blocked
on Facebook:
Sahyujhyahs startup
story
POPU LAR

How one airport trip

caused this 22-yearold college dropout
to build a business
with 6 million unique
POPU LAR
signins
GST registration

computer at 9, and began visiting his family pharma plants from 1999 when he
was 11 back when the concept of generic medicine was quite new in the market
and India was known to only make copy products which are out of patent.

opens: procedure to
enroll for GST
registration by
existing taxpayers

Abhishek Singhs first success was with Tacrolimus Capsules, an

immunosuppressive drug used mainly after allogeneic organ transplant to

lower the risk of organ rejection. This generic launch was as quite popular so
much so that this was tendered by almost 28 countries in a span of 4 years till
the new bio-similar sirolimus Capsule.
Abhishek Singh was offered $300,000 from a Turkey based venture capital
funding billionaire for Tacrolimus; to sell its technology with full rights. He
refused this money, along with the feedback and criticism that selling such right
of a bio-similar which was already not affordable in India; would further mean
deprivation access to such life saving medicines.
The CNBC ran a story on the 21 year olds rise to fame, as well as some unique
advice offered to the young entrepreneur/ young millionaire. Worth a read!
Abhishek Singhs who is satisfied with his companys current global exposure;
highlights that its very easy get investment in pharma company; however, if
greedy investors are allowed on the board of noble pharma companies; the greed
always leads to drug price manipulation and then even though a company may

MOST POPULAR

become large scale, but essential purpose and motto of A.K.Singh from Taj
Pharma may be defeated; i.e. human kind shall not make money from/at the
cost essential life saving medicines and access to medicine shall be basic human
right.
Save web pages as PDF manually or automatically w ith PDFmyURL

POPU LAR

10 crucial mistakes I
want to stop making
in 2017

Makes for a very interesting read!

POPU LAR

India's first female

Olympic wrestler wins
6-year-long 'dangal',
appointed DSP in
Haryana Police
POPU LAR

Kickass Torrents is
back, and it looks like
its here to stay

Readers Poll: Which of these Indian startups positively impacted you?

FACEBOOK

Advertisement

ABOUT THE AUTHOR

Young Entrepreneurs

Save web pages as PDF manually or automatically w ith PDFmyURL

MOST POPULAR
POPU LAR

Meet the Forbes 2016

highest earning
YouTube celebrities

POPU LAR

All set to watch

Dangal? Here are 5
things everyone can
learn from the real
Phogat family
POPU LAR

Have Indias unicorns

been naughty or
nice in 2016?

Sign Up for the daily YS Newsletter for all the

latest updates
Type your email address

Save web pages as PDF manually or automatically w ith PDFmyURL

ABOUT US
TERMS & CONDITIONS

CONTACT US
TEAM YS

FAQS

PRIVACY

TESTIMONIALS

JOBS@YS

DISCLAIMER

PARTNER EVENTS
ADVERTISE

2016 YourStory Media Private Limited. All rights reserved.

Save web pages as PDF manually or automatically w ith PDFmyURL

CODE OF CONDUCT